Kaye, A.D.; Shah, S.S.; Johnson, C.D.; De Witt, A.S.; Thomassen, A.S.; Daniel, C.P.; Ahmadzadeh, S.; Tirumala, S.; Bembenick, K.N.; Kaye, A.M.;
et al. Tacrolimus- and Mycophenolate-Mediated Toxicity: Clinical Considerations and Options in Management of Post-Transplant Patients. Curr. Issues Mol. Biol. 2025, 47, 2.
https://doi.org/10.3390/cimb47010002
AMA Style
Kaye AD, Shah SS, Johnson CD, De Witt AS, Thomassen AS, Daniel CP, Ahmadzadeh S, Tirumala S, Bembenick KN, Kaye AM,
et al. Tacrolimus- and Mycophenolate-Mediated Toxicity: Clinical Considerations and Options in Management of Post-Transplant Patients. Current Issues in Molecular Biology. 2025; 47(1):2.
https://doi.org/10.3390/cimb47010002
Chicago/Turabian Style
Kaye, Alan D., Shivam S. Shah, Coplen D. Johnson, Adalyn S. De Witt, Austin S. Thomassen, Charles P. Daniel, Shahab Ahmadzadeh, Sridhar Tirumala, Kristin Nicole Bembenick, Adam M. Kaye,
and et al. 2025. "Tacrolimus- and Mycophenolate-Mediated Toxicity: Clinical Considerations and Options in Management of Post-Transplant Patients" Current Issues in Molecular Biology 47, no. 1: 2.
https://doi.org/10.3390/cimb47010002
APA Style
Kaye, A. D., Shah, S. S., Johnson, C. D., De Witt, A. S., Thomassen, A. S., Daniel, C. P., Ahmadzadeh, S., Tirumala, S., Bembenick, K. N., Kaye, A. M., & Shekoohi, S.
(2025). Tacrolimus- and Mycophenolate-Mediated Toxicity: Clinical Considerations and Options in Management of Post-Transplant Patients. Current Issues in Molecular Biology, 47(1), 2.
https://doi.org/10.3390/cimb47010002
